Clinical Trial Update: Combining Chemoradiotherapy With Sintilimab in First-Line ICC

View source ↗

Summary

A clinical trial investigating the addition of sintilimab to chemoradiotherapy as first-line treatment for intrahepatic cholangiocarcinoma; the study is not yet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• Sintilimab (sintilimab)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: ICC | Status: NOT_YET_RECRUITING